{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:45:08Z","timestamp":1793832308221,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13054-017-1880-1","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T09:16:48Z","timestamp":1510910208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":172,"title":["Complications of regional citrate anticoagulation: accumulation or overload?"],"prefix":"10.1186","volume":"21","author":[{"given":"Antoine G.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Journois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,19]]},"reference":[{"issue":"9","key":"1880_CR1","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","volume":"33","author":"S Uchino","year":"2007","unstructured":"Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33(9):1563\u201370.","journal-title":"Intensive Care Med"},{"issue":"4","key":"1880_CR2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/cc5937","volume":"11","author":"M Joannidis","year":"2007","unstructured":"Joannidis M, Oudemans-van Straaten HM. Patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11(4):218.","journal-title":"Crit Care"},{"issue":"5","key":"1880_CR3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.1990.300","volume":"38","author":"RL Mehta","year":"1990","unstructured":"Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990;38(5):976\u201381.","journal-title":"Kidney Int"},{"key":"1880_CR4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-015-0822-z","volume":"19","author":"F Stucker","year":"2015","unstructured":"Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, Saudan P. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care. 2015;19:91.","journal-title":"Crit Care"},{"issue":"8","key":"1880_CR5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/CCM.0000000000001004","volume":"43","author":"DJ Gattas","year":"2015","unstructured":"Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R. A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med. 2015;43(8):1622\u20139.","journal-title":"Crit Care Med"},{"issue":"4","key":"1880_CR6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13054-014-0472-6","volume":"18","author":"L Schilder","year":"2014","unstructured":"Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, Vervloet MG, Beishuizen A, Girbes AR, Ter Wee PM, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care. 2014;18(4):472.","journal-title":"Crit Care"},{"issue":"1","key":"1880_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00134-011-2438-3","volume":"38","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med. 2012;38(1):20\u20138.","journal-title":"Intensive Care Med"},{"issue":"12","key":"1880_CR8","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","volume":"41","author":"M Bai","year":"2015","unstructured":"Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098\u2013110.","journal-title":"Intensive Care Med"},{"issue":"2","key":"1880_CR9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, Peters H, Slowinski T. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29(2):265\u201371.","journal-title":"J Crit Care"},{"issue":"1","key":"1880_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2011.32","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group (2012) KDIGO clinical practice guidelines AKI: AKI definition. Kidney Int. 2012;2(1):19\u201336.","journal-title":"Kidney Int"},{"issue":"5","key":"1880_CR11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.jvca.2004.07.016","volume":"18","author":"MF James","year":"2004","unstructured":"James MF, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth. 2004;18(5):581\u20136.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"1880_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000046075","volume":"89","author":"A Calatzis","year":"2001","unstructured":"Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron. 2001;89(2):233\u20136.","journal-title":"Nephron"},{"issue":"6","key":"1880_CR13","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/CCM.0b013e3181a00a92","volume":"37","author":"S Morgera","year":"2009","unstructured":"Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer HH. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med. 2009;37(6):2018\u201324.","journal-title":"Crit Care Med"},{"issue":"1","key":"1880_CR14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2215\/CJN.00040505","volume":"1","author":"AJ Tolwani","year":"2006","unstructured":"Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol. 2006;1(1):79\u201387.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1-3","key":"1880_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000334641","volume":"33","author":"M Balik","year":"2012","unstructured":"Balik M, Zakharchenko M, Otahal M, Hruby J, Polak F, Rusinova K, Stach Z, Vavrova J, Jabor A. Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy. Blood Purif. 2012;33(1-3):80\u20137.","journal-title":"Blood Purif"},{"issue":"1","key":"1880_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcrc.2012.06.003","volume":"28","author":"M Balik","year":"2013","unstructured":"Balik M, Zakharchenko M, Leden P, Otahal M, Hruby J, Polak F, Rusinova K, Stach Z, Tokarik M, Vavrova J, et al. Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration--a comparison between 2 citrate modalities and unfractionated heparin. J Crit Care. 2013;28(1):87\u201395.","journal-title":"J Crit Care"},{"issue":"12","key":"1880_CR17","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1139\/y83-207","volume":"61","author":"PA Stewart","year":"1983","unstructured":"Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol. 1983;61(12):1444\u201361.","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"1880_CR18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.ajkd.2016.04.023","volume":"68","author":"HJ Adrogue","year":"2016","unstructured":"Adrogue HJ, Madias NE. Assessing acid-base status: physiologic versus physicochemical approach. Am J Kidney Dis. 2016;68(5):793\u2013802.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1880_CR19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcrc.2010.02.003","volume":"25","author":"D Nagaoka","year":"2010","unstructured":"Nagaoka D, Nassar Junior AP, Maciel AT, Taniguchi LU, Noritomi DT, Azevedo LC, Neto LM, Park M. The use of sodium-chloride difference and chloride-sodium ratio as strong ion difference surrogates in the evaluation of metabolic acidosis in critically ill patients. J Crit Care. 2010;25(3):525\u201331.","journal-title":"J Crit Care"},{"issue":"2","key":"1880_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1063\/1.1416902","volume":"31","author":"RNKN Goldberg","year":"2002","unstructured":"Goldberg RNKN, Lennen RM. Thermodynamic quantities for the ionization reactions of buffers. J Phys Chem Ref Data. 2002;31(2):231\u2013370.","journal-title":"J Phys Chem Ref Data"},{"issue":"4","key":"1880_CR21","doi-asserted-by":"crossref","first-page":"R162","DOI":"10.1186\/cc11485","volume":"16","author":"C Schultheiss","year":"2012","unstructured":"Schultheiss C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwachter H, Schmid RM, Huber W. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care. 2012;16(4):R162.","journal-title":"Crit Care"},{"key":"1880_CR22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-015-1066-7","volume":"19","author":"T Slowinski","year":"2015","unstructured":"Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, Andersson K, Wehner M, Kozik-Jaromin J, Brett S, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care. 2015;19:349.","journal-title":"Crit Care"},{"issue":"3","key":"1880_CR23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/1744-9987.12280","volume":"19","author":"P Vico De","year":"2015","unstructured":"De Vico P, Messino V, Tartaglione A, Beccaris C, Buonomo C, Talarico D, Prati P, Sabato AF, Colella DF. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction. Ther Apher Dial. 2015;19(3):272\u20138.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"1880_CR24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/cc9358","volume":"15","author":"HM Oudemans-van Straaten","year":"2011","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate? Crit Care. 2011;15(1):202.","journal-title":"Crit Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-017-1880-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T09:16:53Z","timestamp":1510910213000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-017-1880-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1880"],"URL":"https:\/\/doi.org\/10.1186\/s13054-017-1880-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,19]]},"article-number":"281"}}